MedPath

Pre- Versus Post-Incisional Epidural Morphine: Higher Postoperative Pain Perception and Extra Morphine Consumption

Not Applicable
Completed
Conditions
Pain
Interventions
Drug: normal saline 3 ml, morphine 3mg
Registration Number
NCT01095575
Lead Sponsor
Tel-Aviv Sourasky Medical Center
Brief Summary

Background and Objectives: Neuraxial administration of morphine is an effective way of controlling postoperative pain and reducing analgesic consumption. Several animal models have demonstrated that preemptive administration of neuraxial narcotics reduced pain while others revealed the induction of post-incisional hypersensitivity. There have been no consistent results in clinical setting either. This double blind, randomized study compared the effects of PRE- vs. POST-incisional administration of neuraxial morphine on postoperative pain perception and analgesic requirements over 48 hours following laparotomy for open colectomy under standardized general anesthesia.

Methods: Twenty patients received epidural morphine (3 mg) pre-incision and saline after wound closure (MO1 group), and 20 patients received epidural saline before incision and morphine after wound closure (MO2 group). Postoperatively, all patients received boluses of morphine (1.5 mg) via intravenous patient-controlled analgesia (IV-PCA), and rescue doses of intramuscular diclofenac (75 mg) every 6 hours, as needed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

1.adults scheduled for elective laparotomy and colon surgery with the duration of surgery expected to last for at least 2 hours.

Exclusion Criteria
  1. allergy to morphine, fentanyl, non-steroidal anti-inflammatory drugs or any of the intraoperative anesthetic medications
  2. use of opioids, sedatives or stimulants during 21 days prior to surgery, psychiatric illness
  3. congestive heart failure, respiratory failure, neuromuscular disease or presence of a chronic pain syndrome
  4. Pregnant women and patients unable to sign their own consent form

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
group 1normal saline 3 ml, morphine 3mgNS preoperatively and MO postoperatively
group 2normal saline 3 ml, morphine 3mgMO preoperatively and NS postoperatively
Primary Outcome Measures
NameTimeMethod
Subjective pain intensity, using a visual analogue scale (VAS) from 0 (no pain) to 10 (unbearable pain)48 hours
Secondary Outcome Measures
NameTimeMethod
Consumption of analgesics48 hours
© Copyright 2025. All Rights Reserved by MedPath